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Recent developments in stem cell biology have enabled the study of cell fate decisions in
early human development that are impossible to study in vivo. However, understanding how
development varies across individuals and, in particular, the influence of common genetic
variants during this process has not been characterised. Here, we exploit human iPS cell lines
from 125 donors, a pooled experimental design, and single-cell RNA-sequencing to study
population variation of endoderm differentiation. We identify molecular markers that are
predictive of differentiation efficiency of individual lines, and utilise heterogeneity in the
genetic background across individuals to map hundreds of expression quantitative trait loci
that influence expression dynamically during differentiation and across cellular contexts.
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The early stages of human embryogenesis involve dramaticand dynamic changes in cellular states. However, theextent to which an embryo’s genetic background influences
this process has only been determined in a small number of
special cases linked to rare large-effect variants that cause
developmental disorders. This lack of information is critical—it
can provide a deep understanding of how genetic heterogeneity is
tolerated in normal development, when controlling the expres-
sion of key genes is vital. Additionally, with cellular reprogram-
ming becoming an increasingly used tool in molecular medicine,
understanding how inter-individual variability effects such dif-
ferentiations is key.
Critically, recent technological developments have begun to
facilitate such studies in vitro. In particular, the generation of
population-scale collections of human induced pluripotent stem
cells (iPSCs)1,2 has allowed for assessing regulatory genetic var-
iants in pluripotent1,2 as well as in differentiated cells3–5. In
addition, the rapid developments in single-cell RNA-seq now
allow for assessing the molecular impact of genetic variability in a
continuous manner across early human development.
Here, we use a pooled cell differentiation assay to study
endoderm differentiation across a set of human iPSC lines from
125 donor, profiling changes in gene expression via single-cell
RNA-sequencing at four developmental timepoints6. Our study
allows discovery of hundreds of expression Quantitative Trait
Loci (eQTL) that vary across differentiation. We generalise
approaches from studies of the interaction between genotype and
environment (GxE) by leveraging the single-cell resolution of our
study to investigate the interplay between genetic factors and
cellular states. Finally, we also identify gene expression markers of
the differentiation capacity of iPSC lines, highlighting loss of X
chromosome inactivation in female cell lines as an important
cellular phenotype in this system.
Results
Population-scale profiling of differentiating iPS cells. We
considered a panel of well-characterised human iPSC lines derived
from 125 unrelated British donors from the Human Induced
Pluripotent Stem Cell initiative (HipSci) collection1. In order to
increase throughput and mitigate the effects of batch variation, we
exploited a pooled differentiation assay, combining sets of four to
six lines in one well prior to differentiation (28 differentiation
experiments performed in total; hereon “experiments”; Fig. 1a,
Supplementary Fig. 1, 2). Cells were collected at four differentia-
tion time points (iPSC; one, two and three days post initiation—
hereon day0, day1, day2 and day3) and their transcriptomes were
assayed using full-length RNA-sequencing (Smart-Seq27) along-
side the expression of selected cell surface markers using FACS
(TRA-1-60, CXCR4; Supplementary Fig. 3, 4; Methods). Following
quality control (QC), 36,044 cells were retained for downstream
analysis, across which 11,231 genes were expressed (Supplemen-
tary Fig. 5; Methods). Exploiting that each cell line’s genotype acts
as a unique barcode, we demultiplexed the pooled cell populations,
enabling identification of the cell line of origin for each cell
(similar to8,9; Methods). At each time point, cells from between
104 and 112 donors were captured, with each donor being
represented by an average of 286 cells (after QC, Supplementary
Fig. 2; Supplementary Data 1, 2; Methods). The success of the
differentiation protocol was validated using canonical cell-surface
marker expression: consistent with previous studies10, an average
of 72% cells were TRA-1-60(+) in the undifferentiated state
(day0) and an average of 49% of cells were CXCR4(+) three days
post differentiation (day3; Supplementary Fig. 3).
Variance component analysis across all genes (using a linear
mixed model; Methods) revealed the time point of collection as
the main source of variation, followed by the cell line of origin
and the experimental batch (Fig. 1b). Consistent with this, the
first Principal Component (PC) was strongly associated with
differentiation time (Fig. 1c, Supplementary Fig. 6; Methods),
motivating its use to order cells by their differentiation status
(hereafter “pseudotime”, Fig. 1c). Alternative pseudotime infer-
ence methods yielded similar orderings (Supplementary Fig. 7;
Methods).
Critically, the expected temporal expression dynamics of
marker genes that characterise endoderm differentiation was
captured by the ordering of cells along the inferred pseudotime
(Fig. 1d). Exploiting these markers of differentiation progress and
pseudotime, we assigned 28,971 cells (~80%) to one of three
canonical stages of endoderm differentiation: iPSC, mesendoderm
(mesendo) and definitive endoderm (defendo) (Fig. 1c, Supple-
mentary Fig. 8; Methods). A smaller fraction of cells (N= 7073)
could not be confidently assigned to a canonical stage of
differentiation; these cells were heavily enriched for those
collected at day2, when rapid changes in molecular profiles are
expected, reflecting a transitional population of cells.
Pseudo-temporal ordering yields stage-specific eQTL. Moti-
vated by the observation that a substantial fraction of variability
in gene expression was explained by cell-line effects (Fig. 1b), we
tested for associations between common genetic variants and
gene expression at the three defined stages of cell differentiation
(Figs. 1c, 2a). Briefly, for each donor, experiment, and differ-
entiation stage, we quantified each gene’s average expression level
(Methods), before using a linear mixed model to test for cis eQTL,
adapting approaches used for bulk RNA-seq profiles (+/− 250
kb, MAF >5%1; Methods). In the iPSC population (day0), this
identified 1,833 genes with at least one eQTL (denoted eGenes;
FDR <10%; 10,840 genes tested; Supplementary Data 3). To
validate our approach, we also performed eQTL mapping using
deep bulk RNA-sequencing profiles from the same set of iPSC
lines (“iPSC bulk”; 10,736 genes tested) generated as part of the
HipSci project1, yielding consistent eQTL (~70% replication of
lead eQTL effects; nominal P < 0.05; Methods; Supplementary
Data 4). These iPSC eQTL were further confirmed by analysis of
scRNA-seq data generated from a subset of 5 experiments using a
droplet-based approach (Methods; Supplementary Fig. 9, 10).
Analogously, we mapped eQTL in the mesendo and defendo
populations, yielding 1702 and 1342 eGenes, respectively. For
comparison, we also performed eQTL mapping in cells collected
on day1 and day3—the experimental time points commonly used
to identify cells at mesendo and defendo stages6. Interestingly,
this approach identified markedly fewer eGenes (1181 eGenes at
day1, and 631 eGenes at day3), demonstrating the power of using
the single-cell RNA-seq profiles to define relatively homogeneous
differentiation stages in a data-driven manner (Fig. 2b; Methods;
Supplementary Table 1). Notably, this observation did not merely
reflect differences in the number of cells or donors considered
(Supplementary Fig. 11).
Profiling multiple stages of endoderm differentiation allowed
us to assess at which stage along this process individual eQTL can
be detected. We observed substantial regulatory and transcrip-
tional remodelling upon iPS differentiation to definitive endo-
derm, with over 30% of eQTL being specific to a single stage
(Fig. 2a, c; Methods), where we considered the pairwise
replication of eQTL to define stage-specific effects (nominal P <
0.05 and consistent effect direction; Methods). Importantly, we
note that stage-specificity of eQTL was not significantly explained
by stage-specific gene expression (Supplementary Fig. 12). Our
differentiation time course covers developmental stages that have
never before been accessible to genetic analyses of molecular
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traits. Consistent with this, 349 of our eQTL variants at the
mesendo and defendo stages have not been reported in either a
recent iPSC eQTL study based on bulk RNA-seq11, or in a
compendium of eQTL identified from 49 tissues as part of the
GTEx project12 (linkage disequilibrium with lead variants in
GTEx, LD: r2 < 0.2; Methods; Supplementary Data 3).
In addition to these eQTL, we identified lead switching
events for 155 eGenes. Those are two distinct variants for the
same gene that are identified as lead eQTL at different stages of
differentiation (at LD: r2 < 0.2; for example iPSC and defendo in
Fig. 2d; Methods). To investigate the potential regulatory role of
such variants, we examined whether the corresponding genetic
loci also featured changes in histone modifications during
differentiation. Specifically, we used ChIP-Sequencing to profile
five histone modifications associated with promoter and
enhancer usage (H3K27ac, H3K4me1, H3K4me3, H3K27me3,
and H3K36me3) in hESCs that were differentiated towards
endoderm (using the same protocol employed above) and
measured at equivalent time points (i.e. day0, day1, day2, day3;
Methods). Intriguingly, for 20 of the lead switching events, we
observed corresponding changes in the epigenetic landscape
(stage-specific lead variants overlap with stage-specific changes
in histone modification status), suggesting a direct mode of
action (Fig. 2d).
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Fig. 1 Single-cell endoderm differentiation of pooled iPSC lines. a Overview of the experimental design. iPSC lines from 125 genotyped donors were
pooled in sets of 4-6, across 28 experiments, followed by differentiation towards definitive endoderm. Cells were sampled every 24 h (Methods) and
molecularly profiled using scRNA-seq and FACS. https://github.com/ebiwd/EBI-Icon-fonts by EBI Web Development is licensed under CC BY 4.0.
b Variance component analysis of 4,546 highly variable genes, using a linear mixed model fit to individual genes to decompose expression variation into
time point of collection, cell line and experimental batch (Methods). c Top: Principal component analysis of gene expression profiles for 36,044 QC-
passing cells. Cells are coloured by the time point of collection. Bottom: Cells are ordered by pseudotime, defined as the first principal component (PC1).
From left to right, cells transition from a pluripotent state to definitive endoderm. d Single cell expression (y-axis) of selected markers for each
developmental stage, spanning iPSC (NANOG), mesendo (T), and defendo (GATA6) stages, plotted along pseudotime (x-axis).
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Discovery of dynamic eQTL across iPSC differentiation. The
availability of large numbers of cells per donor across the dif-
ferentiation trajectory enabled the analysis of dynamic changes of
eQTL strength at fine-grained resolution. Using a sliding-window
approach (25% cells in each window, sliding along pseudotime by
a step of 2.5% cells), we explored how the joint set of 4422 eQTL
lead variants (4470 SNP-gene pairs) discovered at the iPSC,
mesendo, and defendo stages were modulated by developmental
time. To do this, we reassessed each eQTL in each window, taking
advantage of the full length transcript sequencing to measure
allele-specific expression (ASE) in each window (Methods). Here,
in each window, we quantified the deviation from 0.5 of the
expression of the minor allele at the eQTL (ratio of reads phased
to eQTL variants, Methods). Notably, ASE can be quantified in
each cell and is independent of expression level, thus mitigating
technical correlations between differentiation stage and genetic
effect estimates. As a complementary approach, we also con-
sidered average expression quantifications per window to esti-
mate genetic effects using eQTL mapping (Methods). Both
methods result in a measure of the varying strength of genetic
effects along development, or genetic effect dynamics. Reassur-
ingly, the two approaches were highly consistent across pseudo-
time (Fig. 3a, Supplementary Fig. 13).
To formally test for eQTL effects that change dynamically
across differentiation (dynamic QTL), we tested for associations
between pseudotime and the genetic effect size using a linear
model (genetic effect defined based on ASE at the level of single
cells; likelihood ratio test, considering linear and quadratic
pseudotime), uncovering a total of 899 time dynamic eQTL
(out of the joint set of 4422 eQTL across all stages; FDR < 10%;
Methods), including a substantial fraction of eQTL that were not
stage-specific (Supplementary Data 3). This complements our
earlier analysis based on discrete differentiation stages, which
identified substantial stage-specific effects (Fig. 2a,c), by identify-
ing subtle changes in the relationship between genotype and
phenotype during differentiation. To further explore this set of
genes, we clustered eQTL jointly based on the relative gene
expression dynamics (global expression changes along pseudo-
time, quantified in sliding windows as above, Methods), and on
the genetic effect dynamics (Fig. 3a; Methods). This identified
four basic dynamic patterns (Fig. 3b): decreasing early (cluster A),
decreasing late (cluster B), transiently increasing (cluster C), and
increasing (cluster D). As expected, stage-specific eQTL were
grouped together in particular clusters (e.g. defendo specific
eQTL in cluster D; Supplementary Fig. 14). Notably, the gene
expression dynamics and the eQTL dynamics tended to be
distinct, demonstrating that gene expression level is not the
primary mechanism governing variation in genetic effects. In
particular, genetic effects were not most pronounced when gene
expression was high (Fig. 3c, d, Supplementary Fig. 15).
Distinct combinations of expression and eQTL dynamics result
in different patterns of allelic expression. This is illustrated by the
mesendoderm-specific eQTL for VAT1L. Overall expression of
VAT1L decreases during differentiation, but expression of the
alternative allele is repressed more quickly than that of the
reference allele (Fig. 3c). This illustrates how cis regulatory
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sequence variation can modulates the timing of expression
changes in response to differentiation, similar to observations
previously made in C. elegans using recombinant inbred lines13.
In other cases, the genetic effect coincides with high or low
expression, for example in the cases of THUMPD1 and PHC2
(Fig. 3c). These examples illustrate how genetic variation is
intimately linked to the dynamics of gene regulation.
We next asked whether dynamic eQTL were located in specific
regulatory regions. To do this, we evaluated the overlap of the
epigenetic marks defined using the hESC differentiation time
series with the dynamic eQTL (Fig. 3e, Supplementary Fig. 16).
This revealed an enrichment of dynamic eQTL in H3K27ac,
H3K4me1 (i.e., enhancer marks), and H3K4me3 (i.e. promoter)
marks compared to non-dynamic eQTL (i.e. eQTL that we
identified but did not display dynamic changes along pseudotime,
Fig. 3e), consistent with these SNPs being located in active
regulatory elements.
Cellular environment modulates genetic effects on expression.
Whilst differentiation was the main source of variation in the
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dataset, single cell RNA-seq profiles can be used to characterise
cell-to-cell variation across a much wider range of cell state
dimensions14–16. We identified sets of genes that varied in a co-
regulated manner using clustering (affinity propagation; 8000
most highly expressed genes; Supplementary Data 5; Methods),
which identified 60 modules of co-expressed genes. The resulting
modules were enriched for key biological processes such as cell
differentiation, cell cycle state (G1/S and G2/M transitions),
respiratory metabolism, and sterol biosynthesis (as defined by
Gene Ontology annotations; Supplementary Data 6). These
functional annotations were further supported by transcription
factor binding (e.g., enrichment of SMAD3 and E2F7 targets in
the differentiation and cell cycle modules, respectively (Supple-
mentary Table 2, Supplementary Data 7)). Additionally, expres-
sion of the cell differentiation module (cluster 6; Supplementary
Table 2) was correlated with pseudotime, as expected (R= 0.62;
Supplementary Fig. 7C).
Using the same ASE-based interaction test as applied to
identify dynamic QTL, reflecting ASE variation across pseudo-
time (Fig. 3; Methods), we assessed how the genetic regulation of
gene expression responded to these cellular contexts. Briefly, we
tested for genotype by environment (GxE) interactions using a
subset of four co-expression modules as markers of cellular state,
while accounting for effects that can be explained by interactions
with pseudotime (Fig. 4a; Methods). These four co-expression
modules were annotated based on GO term enrichment, and their
normalised mean expression levels in each cell were taken as
quantitative measures of cell cycle state (G1/S and G2/M
transitions) and metabolic pathway activity (respiratory metabo-
lism and sterol biosynthesis; Methods). This approach extends
previous work using ASE to discover GxE interactions17,18, taking
advantage of the resolution provided by single-cell data. We
identified 668 eQTL that had an interaction effect with at least
one factor (Fig. 4b; FDR < 10%), with many of these eQTL having
no evidence for an interaction with differentiation. Indeed, 369
genes had no association with pseudotime, but responded to at
least one other factor. Conversely, of the 872 dynamic eQTL, 299
were also associated with GxE effects with other factors, whereas
573 were exclusively associated with pseudotime (Fig. 4b,
Supplementary Fig. 17; Supplementary Data 8-10; Methods).
These interactions encompass regulatory effects on genes and
SNPs with important functional roles. Specifically, 95 interaction
eQTL variants overlap with variants previously identified in
genome-wide association studies (GWAS, LD r2 > 0.8; Methods;
Supplementary Data 11). For example, an eQTL for RNASET2
shows sensitivity to cellular respiratory metabolic state (Fig. 4a).
This eQTL SNP is in LD (r2= 0.86) with a GWAS risk variant for
basal cell carcinoma19. Furthermore, an eQTL for SNRPC showed
sensitivity to the G2/M state, and is in LD (r2= 0.92) with a
GWAS risk variant for prostate cancer20 (Fig. 4a). These cellular
factors vary not only across cells in the experiments considered
here, but also across cells in vivo, across individuals, and across
environments. Thus, these examples illustrate the versatility of
our single cell dataset and how it can provide regulatory
information about variants in contexts beyond early human
development.
Finally, we explored whether we could detect higher order
interaction effects, where the genetic effect varies with a cellular
state in different ways along differentiation, effectively testing for
GxExE interactions. To this end, we fitted a linear model with
fixed effects for differentiation and each of the factors, plus a
combined term (factor x pseudotime, Fig. 4b, c; Methods). This
identified 176 genes with significant higher order interactions
between a genetic variant, differentiation, and at least one other
factor (Fi. 4b, c, Supplementary Fig. 17; Supplementary Data 10).
One example is an eQTL for EIF5A, whose ASE was responsive to
G2/M state, especially early in differentiation (Fig. 4c). These
results highlight the context-specificity of eQTL, and the power of
scRNA-seq in dissecting this specificity within one set of
experiments.
Early markers are predictive of differentiation efficiency. Pre-
vious studies have demonstrated that iPSC lines vary in their
capacity to differentiate21. As a measure of differentiation effi-
ciency in our experiments, we used average pseudotime on day3,
and observed significant variation across cell lines, which was
consistent across replicate differentiations of the same cell line
(Fig. 5a). Exploiting the scale of our study and the pooled
experimental design, we set out to identify genetic and molecular
markers of differentiation efficiency that are accessible prior to
differentiation (Methods).
First, we considered the set of 4422 eQTL lead variants at any
of the three developmental stages and tested each variant for
association with differentiation efficiency (using a linear mixed
model; Methods). This only identified a single significant
association, with the eQTL variant for DPH3 (FDR 10%,
Supplementary Data 12). We performed an additional set of
differentiations in HipSci iPSC lines derived from individuals that
were not part of the variant discovery, selected based on genotype
at this variant (n= 20). Differentiation efficiency was measured
by the percentage of CXCR4+ cells on day3. While the direction
of effect was consistent, the association was not statistically
significant (P= 0.24, Student’s t-test), likely reflecting low power
at this sample size. We conclude that larger sample sizes will be
required to definitively reveal genetic determinants of in vitro
differentiation efficiency.
We next asked whether levels of gene expression at the iPSC
stage could represent molecular markers of differentiation
efficiency. This revealed 38 associations (FDR 10%, 11,231 genes
tested; Supplementary Data 13), 9 of which were also observed
when using independent bulk RNA-seq data from the same cell
Fig. 3 eQTL dynamics during differentiation. a Combined analysis of the gene expression, ASE, and eQTL dynamics across pseudotime. Upper panels:
Schematic of sliding window approach. Cells are binned according to pseudotime groups, to quantify average expression, perform an eQTL analysis, and
quantify average ASE (each bin includes 25% of cells, binned at increments of 2.5%). Lower panels: clustered heatmap of expression levels, eQTL effects,
and ASE across pseudotime for the top 311 genes with the strongest dynamic QTL effects (FDR < 1%; out of 785 at FDR < 10%; Methods). For each gene,
the expression and the ASE dynamics were jointly grouped using clustering analysis, with 4 clusters. The membership of gene expression and ASE
dynamics of these 4 clusters is indicated by colours in the right-hand panel. Values in all heatmaps are z-score normalised by row. For ASE, average ASE
values are plotted such that red indicates highest deviation from 0.5. b Summary of the identified cluster dynamics, displaying the average dynamic profile
of each cluster, computed as the average across z-score normalised gene expression/ASE profiles. c Exemplars of the dynamic gene expression and
dynamic genetic effects clusters shown in a. Shaded regions indicate standard error (+/− 1 SEM; Methods). d Number of genes categorised by the
combination of expression and ASE cluster from a. Average dynamics of expression clusters (rows) and ASE clusters (columns) as in b are shown.
e Overlap of dynamic eQTL variants from a with histone marks. The odds ratio compared to the background of all other eQTL variants is shown (*P < 0.01;
**P < 1 × 10−4; Fisher’s exact test).
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lines (replication defined as nominal P < 0.05; Supplementary
Data 13; Methods). We note that expression of these marker
genes is largely orthogonal to pseudotime itself (Supplementary
Fig. 18). As an example, the expression of ZDHHC9 in iPSCs was
negatively associated with differentiation efficiency (Fig. 5b).
Furthermore, ZDHHC9 is one of 17 differentiation-associated
genes located on the X chromosome, reflecting a significant
enrichment of X chromosome genes (24.5-fold enrichment, P=
8 × 10−16, Fisher’s exact test). Higher expression of these genes
was associated with reduced differentiation efficiency (Fig. 5b;
Methods). The majority of these associations persisted when
limiting the analysis to female lines (14/17 at P < 0.05), indicating
variation beyond differences between sexes. These results are
consistent with previous observations that X chromosome
reactivation is a marker of poor differentiation capacity of iPSCs
in general22,23. We did not identify any striking patterns other
than the reported overrepresentation of chromosome X genes,
partly due to a small sample size.
Discussion
Our map of early endoderm differentiation across 125 individuals
offers a unique and powerful tool for interrogating the role
of genetic heterogeneity in early human development. It
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characterises the effects of common genetic variants on gene
expression in mesendoderm and definitive endoderm cells, pro-
viding the first eQTL maps at these key developmental stages. We
exploited this resource to identify hundreds of eQTL that act at
tightly-defined time points during early differentiation, and in
specific cellular states, thus fully utilising the power of single-cell
transcriptomics.
These results illustrate a difference between bulk and single-cell
transcriptomics, as applied to eQTL mapping: the trade-off
between statistical power and cellular resolution. In our analysis
of iPSC, bulk transcriptomes provided higher statistical power for
discovery of eQTL. However, as we have demonstrated, a single-
cell approach allows detailed annotation of changing eQTL effects
across heterogeneous cell types and cell states, with the ability to
better interpret the context-specific role of individual genetic
variants. As single-cell approaches are extended to more disease-
relevant tissues and cell types, this may provide important clues
on the causal role of genetic variants in disease. The single-cell
technology employed also has implications for what can be
assessed. While we found that similar eQTL signals could be
detected with both Smart-seq2 and 10x approaches, the full-
length transcripts of Smart-seq2 allowed quantification of ASE,
which is not possible with the 3′ fragments sequenced using the
10x protocol.
A further advantage of the application of single-cell tran-
scriptomics in this study was to enable the pooling strategy. While
the feasibility of pooling samples has previously been demon-
strated for peripheral blood mononuclear cells8, we have exten-
ded this to cell lines differentiated together in culture. This
provided higher throughput, and enabled the characterisation of
intrinsic line-to-line variation in differentiation efficiency in a
controlled setting. While the endoderm differentiation protocol
considered here is short and efficient, other protocols (e.g., to
generate neurons24) are much more challenging, making a
pooling strategy useful for scaling up these protocols to
population-scale.
Although we have considered replicates of the same line
across different experimental pools, our study is based on a
single iPS line per donor. In the future, experimental designs
may consider multiple lines per donor, which, however, would
require a different barcoding scheme as these cannot be dis-
criminated using genetic barcodes. As a result of this
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experimental design, we cannot definitively distinguish between
donor and line effects.
In summary, our results demonstrate the power of combining
iPSC line pooling and scRNA-seq to investigate development and
genetics in vitro. Sorting of cells by state allows the context-
specificity of eQTL to be probed in detail across many axes of
cellular variation. The scRNA-seq data also provide a rich
description of the progress of differentiation across time in dif-
ferent cell lines. Application of this approach in other contexts
will characterise the genetic component of differentiation across
the spectrum of human development.
Methods
Pooled scRNA-seq profiling during endoderm differentiation. A total of 126
pluripotent stem cell (iPSC) lines derived from 125 donors as part of the HipSci
project were considered for analysis (see Supplementary Data 2 for demographic
information). HipSci cell lines were derived from consented research volunteers
recruited from the NIHR Cambridge BioResource, approved under ethics for iPS
cell derivation (REC 09/H0304/77, V2 04/01/2013, and revised consent REC 09/
H0304/77, V3 15/03/2013). Batches of 4-6 cell lines were co-cultured and grown as
a mixed population for a total of 28 experiments, in 12 well plates. This scales up
our previous work assaying single-cell transcriptomes of individual cell lines25.
Cells were harvested immediately prior to the initiation of differentiation (day0;
iPSCs), and at time points 1, 2, and 3 days post differentiation initiation (day1,
day2, day3). Subsequently, single cells were sorted into 384 well plates. Cells were
processed using Smart-seq2 for scRNA-seq with parallel FACS analysis of the
markers TRA-1-60 and CXCR4 being performed for each cell. A subset of cell lines
were assayed in more than one experiment (33 donors; Supplementary Data 1, 2;
Supplementary Fig. 2). In addition to the differentiation of pools of cell lines by co-
culture for scRNA-seq, cell lines were also differentiated individually and assayed
by FACS for the percentage of CXCR4+ cells on day3, following the same pro-
tocol, in order to validate the genetic association of the DPH3 eQTL variant with
differentiation. These were performed as separate experiments.
Cell culture for maintenance and differentiation. Human iPSC lines were
thawed for differentiation and maintained in Essential 8 (E8) media (LifeTech) on
vitronectin (StemCell Technologies, #07180) coated Corning plates according to
the manufacturer’s instructions. Cells were passaged at least twice after thawing
and always 3–4 days before plating for differentiation to ensure all the cell lines in
each experiment were growing at a similar rate prior to differentiation. Gelatine/
MEF coated plates were prepared 24–48 h before plating for differentiation by
incubating plates with 0.1% gelatine for 20 min at room temp. The gelatine was
then aspirated and plates were incubated in MEF medium overnight at 37 °C.
Immediately prior to plating cells, plates were washed once with D-PBS to remove
any residual MEF medium. To plate for endoderm differentiation, cells were
washed once with D-PBS and dissociated using StemPro Accutase (Life Technol-
ogies, A1110501) at 37 °C for 3 - 5 min. Colonies were fully dissociated through
gentle pipetting. Cells were resuspended in MEF medium, passed through a 40 µm
cell strainer, and pelleted gently by centrifuging at 300g for 5 min. Cells were re-
suspended in E8 media and plated at a density of 15,000 cells per cm2 on gelatin/
MEF coated plates 6,26 in the presence of 10 µM Rock inhibitor—Y27632 (Sigma,
#Y0503 - 5 mg). Media was replaced with fresh E8 free of Rock inhibitor every 24 h
post plating. Differentiation into definitive endoderm commenced 72 h post plat-
ing. Cells were washed 1x gently with D-PBS to remove residual E8. Cells were then
incubated in CDM-PVA containing 100 ng/mL ActivinA (made in house), 80 ng/
mL FGF2 (made in house), 10 ng/mL BMP4 (R&D systems, #314-BP-050), 10 µm
Ly294002 (Promega, #V1201), and 3 µM CHIR99201 (Selleckchem, #S1263) for 24
h (Day 1). After 24 h, the day 1 media was replaced with CDM-PVA containing
100 ng/mL ActivinA, 80 ng/mL FGF2, 10 ng/mL BMP4, and 10 µm Ly294002 for
another 24 h (Day 2). Day 2 media was then replaced with RPMI/B27 containing
100 ng/mL ActivinA and 80 ng/mL FGF2 for another 24 h (Day 3) 6. The overall
efficiency of the differentiation protocol was validated using reference lines with
good and poor differentiation capacity, respectively (Supplementary Fig. 19). Please
refer to the table below (Supplementary Table 3) for compositions of gelatine, MEF
media, CDM-PVA, and RPMI/B27. All media was filtered through 0.22 µm filters
prior to use.
Single cell preparation and sorting for scRNAseq. Cells were dissociated into
single cells using Accutase and washed once with MEF medium as described above
when plating cells for differentiation. For all subsequent steps, cells were kept on ice
to avoid degradation. Approximately 1 × 106 cells were re-suspended in PBS+ 2%
BSA+ 2 mM EDTA (FACS buffer); BSA and PBS were nuclease-free. For staining
of cell surface markers, 1 × 106 cells were re-suspended in 100 µL of ice-cold FACS
buffer containing 20 µL anti-Tra-1-60 antibody (BD Pharmingen, BD560380) and
5 µL of anti-CXCR4 antibody (eBioscience 12-9999-42), and were placed on ice for
30 min. Cells were protected from light during staining and all subsequent steps.
Cells were washed with 5 mL of FACS buffer, passed through a 35 µm filter to
remove clumps, and re-suspended in 300 µL of FACS buffer for live cell sorting on
the BD Influx Cell Sorter (BD Biosciences). Live/dead marker 7AAD (eBioscience
00-6993) was added immediately prior to analysis at a concentration of 2 µL/mL
and only living cells were considered when determining differentiation capacities.
Living cells stained with 7AAD but not TRA-1-60 or CXCR4 were used as gating
controls. Data for TRA-1-60 and CXCR4 staining were available for 31,724 cells, of
the total 36,044. Single-cell transcriptomes of sorted cells were assayed as follows:
reverse transcription and cDNA amplification was performed according to the
SmartSeq2 protocol 7, and library preparation was performed using an Illumina
Nextera kit. Samples were sequenced using paired-end 75 bp reads on an Illumina
HiSeq 2500 machine (one lane of sequencing per 384 well plate).
Immunofluorescence staining. All volumes below are given per well. Cells were
grown in 12 well plates and fixed at 4 °C with 500 μL of 4% paraformaldehyde
(PFA; VWR, #43368.9 M) solution immediately after removing the culture med-
ium. They were then washed three times in D-PBS to remove the fixative.
Unspecific binding was blocked by incubating cells in 500 μL of PBST (0.1% Triton
X-100 in D-PBS) containing 10% donkey serum (AbD Serotec, #C06SB) for 60 min
at room temperature. Cells were then incubated overnight at 4 °C with 300 μL of
primary antibodies diluted in PBST containing 1% donkey serum. Cells were next
washed three times with D-PBS to remove unbound primary antibodies and then
incubated with 300 μL of secondary antibodies diluted in PBST containing 1%
donkey serum in for 1 h at room temperature. Unbound antibodies were removed
by three 5 min washes in D-PBS. 4′,6-Diamidino-2- phenylindole dihydrochloride
(DAPI; Sigma-Aldrich, #D-8417) at a dilution of 1:1000 was added to the first
wash. Antibodies used for immunostaining and their dilutions are listed in Sup-
plementary Table 4.
Fluorescence activated cell sorting (FACS) analysis. Cells were washed twice in
D-PBS and incubated in Accutase for 5 min at 37 °C. The Accutase was neutralised
by adding double its volume of 5% FBS diluted in D-PBS and the cells were fully
dissociated by gentle pipetting. Cells were washed twice in D-PBS then fixed by re-
suspending in 500 μL of 4% PFA solution diluted in D-PBS for 20 min on ice. Fixed
cells were washed twice in D-PBS+ 2% FBS and then stored at 4 °C in BD stain
buffer (BD Pharmingen Cat # 554656) for up to a week prior to analysis. For
staining of intracellular markers, cells were permeabilized in 500 μL of D-PBS
containing 1% Saponin (Sigma-Aldrich, #47036-50G-F) for 30 min at room tem-
perature. Cells were then incubated for 1 h at room temperature with Goat anti-
human Sox17 (R&D, #AF1924, [2 mg/mL]) at a dilution of 1:50 in 100 μL of
Staining Solution (1% Saponin and 5% FBS in D-PBS). Cells were then washed
twice with 1 ml of Staining Solution per wash. To visualise Sox17 staining, cells
were next incubated with Donkey anti-goat 647 (Invitrogen, A21447) at a dilution
of 1:1000 in 100 μL of Staining Solution for 30 min at room temperature. Cells were
washed twice again with 1 mL of Staining Solution per wash and re-suspended in
200 μL of 2% FBS diluted in D-PBS prior to analysis. Analyses were performed
using a BD LRSFortessa cell analyser (BD Biosciences). All flow cytometry
experiments were gated using unstained cells. Data analyses were performed on
FlowJo.
RNA isolation and RT-quantitative (q)PCR. For total RNA isolation, three wells
were individually harvested per condition to obtain biological replicates. The
GenElute Mammalian Total RNA miniprep kit (Merck, #RTN350) and On-
Column DNase I Digestion Set (Merck, #DNASE70) were used to isolate total RNA
and remove contaminating genomic DNA according to the manufacturer’s
instructions. To generate cDNA, 500 ng of RNA, random primer (Promega,
#C1181) and dNTP (Promega, #U1511) were first incubated for 5 min at 65 °C
then quickly chilled on ice to denature the RNA and primer. RNaseOUT
Recombinant Ribonuclease Inhibitor (Invitrogen, # 10777019) and SuperScript II
Reverse Transcriptase (Invitrogen, #18064014) were then added and the tube was
incubated for 10 min at 25 °C for the primer annealing step, 50 min at 42 °C for the
extension step, and finally 15 min at 70 °C for inactivation of the enzyme. The
resulting cDNA was diluted to a final volume of 600 μL with nuclease-free water
prior to use for RT-qPCR. RT-qPCR master mix was prepared using Sensi Mix
Sybr Low Rox Kit (Bioline, #QT625-20). RT-qPCR reactions were performed using
the Mx3005P system (Stratagene) according to the manufacturer’s instructions.
Samples were run in technical triplicates and normalised to PBGD. Gene-specific
primers are listed in Supplementary Table 5.
Genotyping. All iPSC lines were genotyped using the Illumina HumanCoreExome-
12 Beadchip and the genotypes were called using GenomeStudio (Illumina, CA,
USA). Genotypes were then phased using SHAPEIT v2.r79027 and imputed, per
sample, using IMPUTE2 v2.3.128. Imputation was performed based on a joint
reference panel of haplotypes derived from the UK10K cohorts and 1000 Genomes
Phase 1 data27,29. Single-sample VCFs were merged and subsequent QC was per-
formed using Genotype Harmonizer30 and BCFtools. Variants with INFO score
lower than 0.4 were excluded from further analysis. More information on the
genotyping and imputation procedure can be found in Kilpinen et al.1.
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Demultiplexing donors from pooled experiments. Assignment of cells to donors
was performed using Cardelino9. Briefly, Cardelino estimates the posterior prob-
ability of a cell originating from a given donor based on common variants in
scRNA-seq reads, while employing a beta binomial-based Bayesian approach to
account for technical factors (e.g. differences in read depth, allelic drop-out, and
sequencing accuracy). For this assignment step, we considered a larger set of n=
490 HipSci lines with genotype information, which included the 126 lines used in
this study. A cell was assigned to a donor if the model identified the match with
posterior probability >0.9, requiring a minimum of 10 informative variants for
assignment. Cells for which the donor identification was not successful were not
considered further. Across the full dataset 99% of cells that passed RNA QC steps
(below) were successfully assigned to a donor.
scRNA-seq quality control and processing. Adaptors of raw scRNA-seq reads
were trimmed using Trim Galore!31–33, using default settings. Trimmed reads were
mapped to the human reference genome build 37 using STAR34 (version: 020201)
in two-pass alignment mode, using the default settings proposed by the ENCODE
consortium (STAR manual). Gene-level expression quantification was performed
using Salmon35 (version: 0.8.2), using the “--seqBias”, “--gcBias” and “VBOpt”
options using ENSEMBL transcripts (built 75)36. Transcript-level expression values
were summarised at a gene level (estimated counts per million (CPM)) and quality
control of scRNA-seq data was performed with the scater Bioconductor package in
R37. Cells were retained for downstream analyses if they had at least 50,000 counts
from endogenous genes, at least 5000 genes with non-zero expression, less than
90% of counts came from the 100 highest-expressed genes, less than 15% of reads
mapping to mitochondrial (MT) genes, they had a Salmon mapping rate of at least
60%, and if the cell was successfully assigned to a donor (Supplementary Fig. 20).
Dead cells as identified based on 7AAD staining were discarded. Size factor nor-
malisation of counts was performed using the scran Bioconductor package in R38.
Expressed genes with an HGNC symbol were retained for analysis, where expressed
genes in each batch of samples were defined based on (i) raw count >100 in at least
one cell prior to QC and (ii) average log2(CPM+1) >1 after QC. Normalised CPM
data were log transformed (log2(CPM+1)) for all downstream analyses. The joint
dataset was investigated for outlying cell lines or experimental batches, which
identified no clear groups of outlying cells (Supplementary Fig. 21, 22).
As a final QC assessment, we considered possible differences between cell lines
from healthy and diseased donors. In particular, a subset of 11 cell lines were
derived from neonatal diabetes patients, and differentiated together with cell lines
from healthy donors across 7 experiments (out of 28). There was no detectable
difference in differentiation capacity between healthy and neonatal diabetes lines in
these experiments (P > 0.05), and cells from both sets of donors overlapped in
principal component space (Supplementary Fig. 23). Thus, we included cells from
all donors in our analyses irrespective of disease state.
The final merged and QC’ed dataset consisted of 36,044 cells with expression
profiles for 11,231 genes (Supplementary Figs. 2 and 5).
Bulk RNA-Seq quality control and processing. Raw RNA-seq data for 546 HipSci
cell-lines were obtained from the ENA project: ERP007111 and EGA projects:
EGAS00001001137 and EGAS00001000593 (see Data availability). CRAM files
were merged per cell-line and converted to FASTQ format. Processing of the
merged FASTQ files was matched to the single cell processing, as described above.
Samples with low quality RNA-seq were discarded based on the following criteria:
lines with less than 2 billion bases aligned, with less than 30% coding bases, or with
a duplication rate higher than 75%. This resulted in 540 lines for analysis, 108 of
which had matched (day0) single cell RNA-seq data available.
Gene-level expression levels were quantified using Salmon, analogously to the
alignment, as described for the single cells. Gene expression profiles were
normalised using scran, to match the single cell data processing, and the scran
normalised CPM data is log transformed (log2(CPM+1)).
Variance component analysis. Variance component analysis was performed, per
gene, by fitting a random effects model using LIMIX39 to the gene’s expression
profiles across cells. To reduce computational cost, we considered a random subset
of 5000 cells. The experiment, day of collection, and cell line identity were each
included as random effects. Full variance component results for all genes are
provided in Supplementary Data 14.
Highly variable genes. The top highly variable genes were computed using scran’s
trendVar and decomposeVar functions, using a design matrix to correct for the
differentiation experiment-specific effects (i.e., treating each experiment as a dif-
ferent batch). At FDR < 1%, this identified 4546 highly variable genes.
Pseudotime definition. We used the first principal component calculated based on
the top 500 highly variable genes in our set to represent differentiation pseudotime.
This component was linearly re-scaled to take values between 0 (the minimum
value observed for any cell) and 1 (the highest value observed). For comparison, we
considered three alternative methods for defining pseudo time:
(i) We considered diffusion pseudotime (DPT)40 (Supplementary Fig. 7A). The
underlying diffusion map was generated using 15 nearest neighbours and
with gene expression represented by the first 20 PCs across the top 500 most
highly variable genes. DPT analysis was carried out using the default settings
with Scanpy v1.2.241. There was a Pearson correlation of 0.82 between DPT
and the pseudotime definition we used.
(ii) We considered calculating pseudotime by projecting each cell on to the
principal curve of the first two principal components of the top 500 most
highly variable genes (Supplementary Fig. 7B). Principal curve analysis was
performed using the R package princurve42. There was a Pearson correlation
of 0.86 between the principal curve pseudotime and the pseudotime
definition we used.
(iii) We considered representing pseudotime by the mean expression of the
differentiation co-expression module. This gene cluster was enriched for GO
terms associated with differentiation including ‘anatomical structure
morphogenesis’ (GO:0009653), ‘anterior/posterior pattern specification’
(GO:0009952), and ‘response to BMP’ (GO:0071772) (Supplementary
Table 2, Supplementary Data 6; Supplementary Fig. 7C). There was a
Pearson correlation of 0.64 between the differentiation co-expression
module and the pseudotime definition we used. The lower concordance
between pseudotime and this module is consistent with the limited set of
genes included—the coexpression module only includes genes upregulated
during differentiation, and therefore uses no information from changes in
expression of pluripotency-associated genes.
Assignment of cells to developmental stages. The stage labels post iPSC
(mesendo and defendo) were defined using a combination of differentiation stages
obtained using the single-cell defined pseudotime and knowledge based on cano-
nical marker genes. Cells were assigned to the mesendo stage if they were collected
at day1 or day2, and had pseudotime values between 0.15 and 0.5, corresponding to
a pseudotime window around the peak expression of Brachyury (T), a marker of
mesendoderm (Supplementary Fig. 8A). Cells were assigned to the defendo stage if
they were collected at day2 or day3, and had pseudotime values higher than 0.7,
corresponding to a pseudotime window with maximal expression of GATA6, a
marker of definitive endoderm (Supplementary Fig. 8B). Cells with intermediate
pseudotime (between 0.5 and 0.7) mostly came from day2, and were not assigned
to any stage for the purposes of the initial stage QTL mapping (results shown in
Fig. 2, Supplementary Table 1). Overall, we assign 28,971 (80%) cells to any of the
stages (iPSC, mesendo, defendo).
cis eQTL mapping. A consistent eQTL mapping strategy was applied to bulk RNA-
seq expression and expression traits derived from scRNA-seq. We considered
common variants (minor allele frequency >5%) within a cis-region spanning 250 kb
up- and downstream of the gene body for cis QTL analysis. Association tests were
performed using a linear mixed model (LMM), accounting for population structure
and sample repeat structure (see below) as random effects (using a kinship matrix
estimated using PLINK43), with no observed confounding between population
structure and experimental batch (Supplementary Fig. 24). All models were fitted
using LIMIX39. The values of all features were standardised and the significance
was tested using a likelihood ratio test (LRT). To adjust for experimental batch
effects across samples, we included the first 10 principal components calculated on
the expression values in the model as covariates. These batch effects usually affect
the expression of many genes, and therefore are detectable in the principal com-
ponents of expression. Furthermore, such global batch effects are orthogonal to the
effects of a single cis regulatory variant on the expression of one gene. This
approach is similar to that applied in conventional bulk eQTL analyses1. In order
to adjust for multiple testing, we used an approximate permutation scheme, ana-
logous to the approach proposed in44. Briefly, for each gene, we generated 1000
permutations of the genotypes while keeping covariates, kinship, and expression
values fixed. We then adjusted for multiple testing using this empirical null dis-
tribution. To control for multiple testing across genes, we then applied the Storey
procedure45. Genes with significant eQTL were reported at an FDR < 10%.
Mapping cis eQTL across three stages of differentiation. To map eQTL based
on scRNA-seq profiles, we quantified average gene expression profiles (log2(CPM
+1)) across cells for each (donor, day of collection, experiment) combination. This
approach retains differences across experiments and days, for cells from the same
donor, and is enabled by the pooled experimental design. Accounting for popu-
lation structure using a kinship matrix is especially important in this context, since
aggregated expression values for the same donor from different experiments are
essentially replicates and hence genetically identical. We separately mapped eQTL
for each differentiation stage (i.e. iPSC, mesendo, defendo), yielding 1833 (10,840
tested), 1702 (10,924 tested) and 1342 (10,901 tested) genes with an eQTL
respectively (FDR < 10%). eQTL results are provided in Supplementary Data 3).
For comparison, we performed analogous QTL analyses using all cells from
day1, and day3 instead of the pseudotime-based differentiation stages. This
approach resulted in 1181 (10,787 tested) and 631 (10,765 tested) genes with an
eQTL at day 1 and 3 respectively (Supplementary Table 1).
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Mapping dynamic eQTL (visualisation purposes only). We performed eQTL
mapping across a sliding window on pseudotime, considering bins that contain
25% of all cells, sliding along the pseudotime by a step of 2.5% of cells (Fig. 3a, top
middle panel). Similarly to the approach taken for eQTL analysis in individual
differentiation stages, expression values are averaged by (donor, day, experiment)
combinations, within each window.
Mapping cis eQTL in iPSCs with bulk RNA-seq. To perform cis-eQTL mapping
in the bulk RNA-seq data, we considered cell lines that had been used to map iPSC
eQTL from the scRNA-seq data (bulk data was available for 108 donors out of the
112 day0 single cell donors), and tested the same set of genes. This yielded
2908 significant genes at an FDR of 10% (out of 10,736 genes tested).
To compare the iPSC eQTL maps derived from bulk and single-cell RNA-seq
data, we assessed the nominal significance (P < 0.05) as well as the consistent
direction of effect of single-cell iPSC eQTL lead variants (top variant per gene) in
the full set of results from the bulk iPSC eQTL analysis and vice versa.
SNP tagging. We used LD tagging to account for linkage disequilibrium (LD)
effects that might cause false positive lead switches and to identify links between
GWAS implicated variants and eQTL. To this end, we calculated the LD between
lead eQTL variants and either GWAS variants or other eQTL lead variants, using
both the 1000 genomes phase3 reference panel and the HipSci dataset to calculate
LD between SNPs, taking the union of both sets.
Lead switching event quantification. Lead switching events were defined as two
or three distinct variants that were identified at distinct differentiation stages,
found to be significantly associated (FDR < 10%) with the same genes, and that
were not in LD (r2 < 0.2).
GWAS tagging. We performed GWAS tagging using an LD threshold of r2 > 0.8.
We considered all GWAS variants from the GWAS catalogue as available as part of
ENSEMBL 9446, for all traits and diseases. This analysis was restricted to variants
that reached genome-wide significance (P < 5e-8) for any of the traits.
Allele-specific expression quantification. Duplicated reads were removed from
the STAR alignments using Picard Tools (http://broadinstitute.github.io/picard).
ASE was quantified at the gene level relative to a heterozygous eQTL lead variant.
As a result, for a given eQTL, ASE was only quantified across cells from donors
heterozygous for that eQTL variant. This was done following five steps (see Sup-
plementary Fig. 25 for a worked example of one gene in one cell): (1) ASE counts
were obtained using GATK tools v3.7 in ASEReadCounter mode, with the settings
“-minDepth 1 -minMappingQuality 10 -minBaseQuality 2 -rf DuplicateRead”. ASE
of a SNP in a given cell was quantified if (i) the cell was heterozygous for that SNP,
based on the known donor genotypes, and (ii) the SNP was located in an exonic
region (ENSEMBL 75 annotation, as above). The output from GATK tools gives
the number of reads mapping to the alternative and reference alleles for each
heterozygous SNP in each cell. (2) For each cell, ASE quantifications for each SNP
were converted from “alternative allele reads” to “chrB allele reads” using the
known phase (indicated as chrA|chrB, where 0= reference, 1= alternative) of each
SNP in each donor (e.g. for a SNP with the phase “1|0”, the alternative allele is on
chrA, so the number of reads mapping to chrB= number of reference allele reads
= total number of reads—number of alternative allele reads). Thus, for each cell,
ASE for all SNPs was quantified relative to the genotypes of the chromosomes of
that individual, rather than to “reference” or “alternative” alleles. (3) Aggregation of
ASE from SNP-level to gene-level. For each gene, this was done by summing the
“chrB allele reads” and “total reads” across all SNPs contained in the exons of that
gene (as described in the ENSEMBL 75 GTF file). (4) Conversion of quantifications
from “chrB allele reads” to “reads from the chromosome containing the alternative
allele of the eQTL SNP”, again by using the available phasing information. For each
eQTL (i.e. each gene-SNP pair), this provides a consistent definition of ASE across
all cells heterozygous for the eQTL SNP (i.e., across cells from multiple donors).
Donors that are not heterozygous at the eQTL variant of interest were not used for
quantification. (5) Conversion to allelic fractions i.e. quantifications express the
allelic reads as a fraction of the total number of reads.
Mapping of dynamic and interaction eQTL using ASE. ASE quantifies the
relative expression of one allele over the other. If one of these alleles is more
responsive to a particular environmental factor (e.g., because of preferential tran-
scription factor binding), then ASE is expected to vary systematically with that
factor. This observation has previously been used to identify GxE interactions in
gene expression across individuals17. Here, we applied similar concepts to single-
cell RNA-seq, testing for the influence of cellular environmental factors (i.e., cel-
lular processes) on ASE in individual cells. Importantly, these ASE tests are
internally matched, as potentially confounding batch effects and technical variation
affect both alleles in each cell similarly.
Three sets of tests were performed, in a linear modelling framework (Fig. 4,
Supplementary Fig. 17; Supplementary Data 13):
(1) Testing for dynamic eQTL i.e. where ASE depends on pseudotime
(“pseudo”). The ASE of each gene-eQTL pair was jointly tested for linear and
quadratic dependence on pseudotime (two degrees of freedom likelihood ratio
test), across all cells in which ASE was quantified for that pair:
ASE ¼ pseudoþ pseudo2 þ ε ð1Þ
(2) Pseudotime-corrected linear cellular factor test. As (1), but with each of 4
cellular factors (“factor”) (respiratory metabolism, sterol biosynthesis, G1/S
transition and G2/M transition) and linear and quadratic pseudotime included as
covariates (note that these covariates are included regardless of whether an eQTL
was identified as dynamic in test (1)):
ASE ¼ pseudoþ pseudo2 þ factorþ ε ð2Þ
(3) Pseudotime-factor interaction test. As (2), but testing for the additional
effect of (pseudotime x factor) included as a covariate:
ASE ¼ pseudo þ pseudo2 þ factorþ ðpseudo´ factorÞ þ ε ð3Þ
In each case, tests were only performed for eQTL for which ASE was quantified
in at least 50 cells. Tests were performed using the statsmodels package in Python
(likelihood ratio test). Multiple testing correction was performed independently for
each of the three sets of tests, using Benjamini-Hochberg correction.
Binning ASE across pseudotime. For visualising ASE as a function of pseudotime
or other cellular factors, we averaged ASE across bins of 25% of cells, as done for
the sliding window eQTL analysis (above). For each (eQTL x bin) combination, the
mean ASE, number of cells, standard deviation, and standard error of the mean
(SEM) was calculated (noting that, while each bin contains an equal number of
cells, not all cells have quantified ASE for each gene). For each eQTL, to calculate
the dynamics of allelic expression across pseudotime (i.e., the expression of tran-
scripts from the ALT and REF chromosomes, as plotted in Fig. 3c), two calcula-
tions were performed. First, the mean expression of each gene across the
pseudotime bins was calculated using all cells heterozygous for the eQTL SNP (i.e.,
the cells in which ASE was quantified). The expression of each allele in each
pseudotime bin was then calculated by taking the mean ASE+/− SEM, multiplied
by the mean expression of that gene (in CPM) in that bin.
Coexpression and covariation clustering. Grouping of pseudotime-smoothed
gene expression and allele-specific expression (see below) was performed by
spectral clustering, as implemented by the Python scikit-learn library (Fig. 3). The
negative of the Pearson correlation was used as the dissimilarity metric. A range of
cluster numbers were tried, with N= 4 judged to be the most clusters possible
before highly correlated pairs of clusters were observed.
Grouping of genes by single-cell co-expression was performed using affinity
propagation47, as implemented by the Python scikit-learn library48. The Pearson
correlation across all cells was used as the similarity/‘affinity’ metric. The top 8,000
highest expressed genes were included in this clustering (as judged by average
expression across all cells). This generated a set of 60 co-expression clusters. GO
enrichment of each cluster was performed by Fisher’s exact test in Python using
GOATOOLS49, and results are listed in Supplementary Data 6 (FDR 10%).
Exemplar co-expression clusters were selected to represent 4 dimensions of
cellular state (Fig. 4a, Supplementary Table 2): cell cycle G1/S transition (cluster
10), cell cycle G2/M transition (cluster 30), cellular respiration (cluster 0), and
sterol biosynthesis (cluster 28). This selection was done according to two criteria:
(1) strongest enrichment of relevant GO terms. The co-expression clusters showed
the largest overrepresentation of genes for the GO terms ‘G1/S transition of mitotic
cell cycle’ (GO:0000082; cluster 10), ‘G2/M transition of mitotic cell cycle’
(GO:0000086; cluster 30), ‘respiratory electron transport chain’ (GO:0022904;
cluster 0), and ‘sterol biosynthetic process’ (GO:0016126; cluster 28). (2) a priori
expectation of sources of cell-to-cell variation. Variation in cell cycle stage is a
common feature of single-cell datasets14, while variation in metabolic state during
iPSC differentiation is well known50.
ChIP-seq experiments and data processing. ChIP-seq was performed using
FUCCI-Human Embryonic Stem Cells (FUCCI-hESCs, H9 from WiCell) in a
modified endoderm differentiation protocol to that used for the iPSC differentia-
tions (see details below). Cells were grown in defined culture conditions as
described previously51. Pluripotent cells were maintained in Chemically Defined
Media with BSA (CDM-BSA) supplemented with 10 ng/mL recombinant Activin A
and 12 ng/mL recombinant FGF2 (both from Dr. Marko Hyvonen, Dept. of Bio-
chemistry, University of Cambridge) on 0.1% Gelatin and MEF media coated
plates. Cells were passaged every 4–6 days with collagenase IV as clumps of 50–100
cells. The culture media was replaced 48 h after the split and then every 24 h.
The generation of FUCCI-hESC lines is based on the FUCCI system (52,53).
hESCs were differentiated into endoderm as previously described54. Following
FACS sorting, Early G1 (EG1) cells were collected and immediately placed into the
endoderm differentiation media and time-points were collected every 24 h up to 72
h. Endoderm specification was performed in CDM with Polyvynilic acid (CDM-
PVA) supplemented with 20 ng/mL FGF2, 10 µM Ly-294002 (Promega), 100 ng/
mL Activin A, and 10 ng/mL BMP4 (R&D).
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We performed ChIP-sequencing for various histone marks (H3K4me3,
H3K27me3, H3K4me1, H3K27ac, H3K36me3) (see Supplementary Table 6 for
antibodies), on two biological replicates per condition55. At the end of the ChIP
protocol, fragments between 100 bp and 400 bp were used to prepare barcoded
sequencing libraries. 10 ng of input material for each condition were also used for
library preparation and later used as a control during peak calls. The libraries were
generated by performing 8 PCR cycles for all samples. Equimolar amounts of each
library were pooled and this multiplexed library was diluted to 8pM before
sequencing using an Illumina HiSeq 2000 with 75 bp paired-end reads.
Reads were mapped to GRCh38 reference assembly using BWA56. Only reads
with mapping quality score ≥10 and aligned to autosomal and sex chromosomes
were kept for further processing. Peak calling analysis57 was performed using
PeakRanger58, and only the peaks that were reproducible at an FDR of ≤0.05 in two
biological replicates were selected for further processing. Peak calling was done
using appropriate controls with the tool peakranger 1.18 in modes ranger
(H3K4me3, H3K27ac; ‘-l 316 -b 200 -q 0.05’), ccat (H3K27me3; ‘-l 316 --win_size
1000 --win_step 100 --min_count 70 --min_score 7 -q 0.05’) and bcp (H3K4me1,
H3K36me3; ‘-l 316’). Adjacent peak regions closer than 40 bp were merged using
the BEDTools suite59, and those overlapping ENCODE blacklisted regions were
filtered out (ENCODE Excludable Mappability Regions60). Finally, peaks were
converted to GRCh37 coordinates using UCSC LiftOver [68].
Identification of markers for differentiation efficiency. Differentiation efficiency
for each cell line was defined as its average pseudotime across cells at day3,
quantified for each experiment and unique donor. To test for associations with
molecular markers, we considered stage-specific gene expression levels, again
quantified for each donor and experiment (as log2(CPM+1)).
Three sets of tests were performed. In each case, models were fitted using the
lme4 package in R61, and significance was determined by the Likelihood ratio test.
The tested model was:
Differentiation efficiency ¼ Marker þ Experiment þ Donorþ ε ð4Þ
Where Experiment is a random effect grouping sets of samples from the same
experiment, and Donor is a random effect grouping samples from the same
donor (and cell line). Two sets of Markers were tested—genetic markers
(i.e., eQTL SNPs), and expression markers (i.e. expression levels in the iPSC
stage/day0), and are presented in Tables S14, S15, respectively. For genetic
markers, tests were limited to the lead eQTL variant per eGene and
differentiation stage.
Genetic markers were validated using data from independent differentiations of
individual cell lines. Here, the percentage of CXCR4+ on day 3 (as measured by
FACS) was used as a measure of differentiation efficiency, with the following
model:
% CXCR4þ ¼ Markerþ ε ð5Þ
The association identified at FDR 10%, with the eQTL variant for DPH3, was
tested using data from other cell lines selected according to their genotype at
this locus.
Expression markers were validated by comparison to bulk RNA-sequencing at
the iPSC stage (day0). In particular, we tested the association between gene
expression in the same cell lines, assayed in separate experiments by bulk RNA-seq
of iPSCs, with differentiation efficiency in our experiments, using the model:
Differentiation efficiency ¼ Marker bulk expression in iPSCsþ ε ð6Þ
Results of the replication p-values and directions of effect are provided in
Supplementary Data 13.
To evaluate whether donor sex had a significant effect on differentiation, we fit
the following linear mixed model:
Differentiation efficiency ¼ Sexþ Experiment þ Donorþ ε ð7Þ
In this model Sex was modelled as a fixed effect and tested for significance using
likelihood ratio test, and Experiment and Donor were modelled as random effects,
as above.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All HipSci data can be accessed from http://www.hipsci.org. Bulk RNA-seq data are
available under accession numbers: ERP007111 (ENA project) and EGAS00001001137,
EGAS00001000593 (EGA projects). Single cell RNA-seq data are available under the
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